Interview with Edwin Harvey, Managing Director, Biogen Idec Argentina
Biogen Idec’s arrival in Argentina has been very recent. Could you explain to our readers why the time was right to take back your licences and to set up in…
Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec’s significant products that address diseases such as multiple sclerosis (MS), lymphoma and rheumatoid arthritis. In 2008, Biogen Idec’s total revenues grew 29 percent over 2007 to $4.1 billion. Biogen Idec is headquartered in Cambridge, Massachusetts, with international headquarters in Zug, Switzerland. They have additional offices in the US, Canada, Australia, Japan and throughout Europe. Biogen Idec has a direct commercial presence in 29 markets, a network of distribution partners in more than 70 additional markets and operations in several new markets, including Central/Eastern Europe, Brazil, China and India.
Contact Info
Biogen Idec Argentina
Av. del Libertador 350 – 7th Floor
1638 Vicente Lopez – Buenos Aires
Argentina
Phone: +54 11 5550 8150
Fax: +54 11 4718 0805
www.biogenidec.com.ar
Biogen Idec’s arrival in Argentina has been very recent. Could you explain to our readers why the time was right to take back your licences and to set up in…
The Bayer Schering merger in 2006 saw you add Argentina and Bolivia to your existing responsibilities as General Manager of Schering for Paraguay and Uruguay. What have been some of…
It’s safe to assume that everywhere that IMS Health is established, there’s also a flourishing pharmaceutical industry. Could you give us an overview of Argentina’s IMS operations? IMS has been…
¿Cual fue la visión de la creación de ANMAT y las circunstancias de su creación? En el momento de la creación del ANMAT, el Gobierno Nacional entendió las necesidades de…
Boasting three Nobel Prize winners from the life sciences, Argentina has had a long history of innovation. Immigration from Europe at the end of the 19th century saw the…
¿Cual fue la visión detrás de la creación de IBC y Dromex? Nuestro negocio original consistía en representar comercialmente a los fabricantes de APIs europeos. Esto me llevo a tender…
¿Cuál es la historia de Laboratorios Poen y como ha crecido en los últimos años? Poen se inició siendo un pequeño laboratorio de capitales nacionales dedicado fundamentalmente a la oftalmología.…
You were General Manager of Pfizer Peru and Pfizer Venezuela before taking on the challenge of the Argentinean market. How difficult was the experience of adjusting to this unique environment?…
¿Porque fue creado en Ministerio de Ciencia y Tecnología, con que visión? Muchos países están aportando importancia a la ciencia y tecnología y representa la razón del desarrollo económico y…
When we spoke to Javier Lombar of IMS Argentina, he explained that a lot of multinational companies use Argentina as a base for regional operations. How does Janssen-Cilag operate in…
Through your work as member of the Council of the IFPMA, as well as FIFARMA, and CAEMe, you must have a very developed and unique perspective on the characteristics of…
The appointment of Lino Barañao and the establishment of the Ministry of Science and Technology suggest that the government has realised what a large role innovation can play in the…
See our Cookie Privacy Policy Here